| The inflammatory response in myocardial infarction NG Frangogiannis, CW Smith, ML Entman Cardiovascular research 53 (1), 31-47, 2002 | 2821 | 2002 |
| The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis SD Prabhu, NG Frangogiannis Circulation research 119 (1), 91-112, 2016 | 2128 | 2016 |
| The pathogenesis of cardiac fibrosis P Kong, P Christia, NG Frangogiannis Cellular and molecular life sciences 71, 549-574, 2014 | 1790 | 2014 |
| The inflammatory response in myocardial injury, repair, and remodelling NG Frangogiannis Nature Reviews Cardiology 11 (5), 255-265, 2014 | 1684 | 2014 |
| Regulation of the inflammatory response in cardiac repair NG Frangogiannis Circulation research 110 (1), 159-173, 2012 | 1443 | 2012 |
| TGF-β signaling in fibrosis A Biernacka, M Dobaczewski, NG Frangogiannis Growth factors 29 (5), 196-202, 2011 | 1392 | 2011 |
| The role of TGF-β signaling in myocardial infarction and cardiac remodeling M Bujak, NG Frangogiannis Cardiovascular research 74 (2), 184-195, 2007 | 1257 | 2007 |
| Transforming growth factor (TGF)-β signaling in cardiac remodeling M Dobaczewski, W Chen, NG Frangogiannis Journal of molecular and cellular cardiology 51 (4), 600-606, 2011 | 1159 | 2011 |
| Transforming growth factor–β in tissue fibrosis NG Frangogiannis Journal of Experimental Medicine 217 (3), 2020 | 907 | 2020 |
| The immune system and cardiac repair NG Frangogiannis Pharmacological research 58 (2), 88-111, 2008 | 904 | 2008 |
| CCL2/Monocyte Chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts O Dewald, P Zymek, K Winkelmann, A Koerting, G Ren, T Abou-Khamis, ... Circulation research 96 (8), 881-889, 2005 | 870 | 2005 |
| Cardiac fibrosis NG Frangogiannis Cardiovascular research 117 (6), 1450-1488, 2021 | 797 | 2021 |
| Pathophysiology of myocardial infarction NG Frangogiannis Comprehensive Physiology 5 (4), 1841-1875, 2011 | 774 | 2011 |
| Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities NG Frangogiannis Molecular aspects of medicine 65, 70-99, 2019 | 773 | 2019 |
| The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction M Dobaczewski, C Gonzalez-Quesada, NG Frangogiannis Journal of molecular and cellular cardiology 48 (3), 504-511, 2010 | 727 | 2010 |
| Resident cardiac mast cells degranulate and release preformed TNF-α, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion NG Frangogiannis, ML Lindsey, LH Michael, KA Youker, RB Bressler, ... Circulation 98 (7), 699-710, 1998 | 726 | 1998 |
| Aging and cardiac fibrosis A Biernacka, NG Frangogiannis Aging and disease 2 (2), 158, 2011 | 663 | 2011 |
| Fibroblasts in myocardial infarction: a role in inflammation and repair AV Shinde, NG Frangogiannis Journal of molecular and cellular cardiology 70, 74-82, 2014 | 596 | 2014 |
| The extracellular matrix in myocardial injury, repair, and remodeling NG Frangogiannis The Journal of clinical investigation 127 (5), 1600-1612, 2017 | 553 | 2017 |
| The role of α-smooth muscle actin in fibroblast-mediated matrix contraction and remodeling AV Shinde, C Humeres, NG Frangogiannis Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1863 (1), 298-309, 2017 | 545 | 2017 |